首页> 外文期刊>OncoTargets and therapy >LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells
【24h】

LncRNA NEAT1 Promotes Proliferation, Migration And Invasion Via Regulating miR-296-5p/CNN2 Axis In Hepatocellular Carcinoma Cells

机译:LNCRNA Neat1通过调节肝细胞癌细胞中的miR-296-5p / cnn2轴来促进增殖,迁移和侵袭

获取原文
           

摘要

Background: Emerging evidence has revealed that long noncoding RNA nuclear paraspeckle assembly transcript 1 (lncRNA NEAT1) is implicated in the development of various cancers. However, the underlying molecular mechanisms of NEAT1 in hepatocellular carcinoma (HCC) remain unclear. Methods: The expression of NEAT1, miR-296-5p and Calponin 2 (CNN2) was detected by quantitative real-time polymerase chain reaction or Western blot, respectively. Cell proliferation and apoptosis were analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay or flow cytometry, respectively. Transwell assay was used to determine cell migration and invasion. The interaction between miR-296-5p and NEAT1 or CNN2 was analyzed by dual-luciferase reporter assay and RIP assay. Huh7 cells transfected with sh-NEAT1 were used to establish the murine xenograft model. Results: NEAT1 was elevated in HCC tissues and cell lines. Knockdown of NEAT1 significantly inhibited proliferation, migration and invasion of HCC cells in vitro as well as tumor growth in vivo. NEAT1 was a sponge of miR-296-5p and remarkably reduced the level of miR-296-5p in HCC cells. Furthermore, NEAT1 silence significantly decreased the expression of CNN2, which was the direct target of miR-296-5p. Besides that, the tumor suppression caused by NEAT1 silence could be rescued by CNN2 restoration or miR-296-5p inhibition in vitro. Additionally, NEAT1 indirectly regulated CNN2 expression by competing to miR-296-5p in vitro and in vivo. Conclusion: LncRNA NEAT1 contributes to HCC progression by regulating miR-296-5p/CNN2 axis, providing a novel regulatory mechanism for HCC development and a promising therapeutic target for the HCC treatment.
机译:背景:出现的证据表明,长期非编码RNA核paraSpere组装转录物1(LNCRNA Neat1)涉及各种癌症的发育。然而,Neat1在肝细胞癌(HCC)中的底层分子机制仍然不清楚。方法:通过定量的实时聚合酶链反应或蛋白质印迹检测Neat1,miR-296-5p和Calponin 2(CNN2)的表达。通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴铵(MTT)测定或流式细胞术分析细胞增殖和细胞凋亡。 Transwell测定用于确定细胞迁移和侵袭。通过双荧光素酶报告器测定和RIP测定分析MiR-296-5P和Neat1或CNN2之间的相互作用。用SH-Neat1转染的HuH7细胞用于建立鼠异种移植模型。结果:Neat1在HCC组织和细胞系中升高。 Neat1的敲低显着抑制了体外HCC细胞的增殖,迁移和侵袭以及体内肿瘤生长。 Neat1是miR-296-5p的海绵,并且显着降低了HCC细胞中miR-296-5p的水平。此外,Neat1沉默显着降低了CNN2的表达,即miR-296-5p的直接靶标。除此之外,通过体外CNN2恢复或miR-296-5p抑制可以拯救由Neat1静默引起的肿瘤抑制。另外,Neat1通过在体外和体内竞争MiR-296-5P来间接调节CNN2表达。结论:LNCRNA NEAT1通过调节miR-296-5p / cnn2轴来提高HCC进展,为HCC开发提供一种新的调节机制以及HCC治疗的有希望的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号